THE authors demonstrated that in vivo administered Lcarnitine strongly ameliorated the immune response in both healthy individuals receiving Intralipid and ageing subjects with cardiovascular diseases, as shown by the enhancement of mixed lymphocyte reaction. Notably, in the latter group L-carnitine treatment also resulted in a significant reduction of serum levels of both cholesterol and triglycerides. Therefore, the hypothesis is that L-carnitine supplementation could ameliorate both the dysregulated immune response and the abnormal lipid metabolism in several conditions.
Introduction
Carnitine (3-hydroxy-4-methyl-ammoniobutanoate) is an essential intracellular constituent in higher animals which is synthesized from peptide bound lysine. 1 '2 In meat and dairy products, carnitine is easily and almost completely absorbed, but endogenous biosynthesis can meet normal metabolic requirements of healthy adults. 3 Almost all the body stores are in skeletal and cardiac muscles (98%), whereas liver and extracellular fluids contain only 1-6% of whole-body carnitine. 4 L-carnitine, the (Table 3) . Notably, skin test reactivity increased in the same patients in whom a reduction of serum lipid levels was observed following -carnitine treatment. Similarly, MLR was increased when the cells were 
